Fineline Cube

Follow:
14435 Articles
Bayer Files for Eylea 8 mg EMA Approval to Extend AMD, DME Treatment Intervals
CompanyDrug

Bayer Files for Eylea 8 mg EMA Approval to Extend AMD, DME Treatment Intervals

Bristol-Myers Squibb's Breyanzi Hits Primary Endpoint in Lymphoma Study
CompanyDrug

Bristol-Myers Squibb’s Breyanzi Hits Primary Endpoint in Lymphoma Study

CSPC Pharmaceutical's SYH2039 Wins FDA Clinical Approval for Advanced Tumors
CompanyDrug

CSPC Pharmaceutical’s SYH2039 Wins FDA Clinical Approval for Advanced Tumors

Boehringer Ingelheim's Nerandomilast Hits Primary Endpoint in PPF Phase III Study
CompanyDrug

Boehringer Ingelheim’s Nerandomilast Hits Primary Endpoint in PPF Phase III Study

CSPC Pharmaceutical's Omalizumab Biosimilar Wins NMPA Approval for Allergic Asthma
CompanyDrug

CSPC Pharmaceutical’s Omalizumab Biosimilar Wins NMPA Approval for Allergic Asthma

Kelun-Biotech to Present SKB264/MK-2870 Data for Urothelial Carcinoma at ASCO-GU 2025
CompanyDrug

Kelun-Biotech to Present SKB264/MK-2870 Data for Urothelial Carcinoma at ASCO-GU 2025

Sinopep-Allsino Wins NMPA Approval for Generic Liptruzet in China
CompanyDrug

Sinopep-Allsino Wins NMPA Approval for Generic Liptruzet in China

R-Nanoablation Raises USD 13.7M in Series B+ to Advance Nanosecond Ablation Tech
CompanyDeals

R-Nanoablation Raises USD 13.7M in Series B+ to Advance Nanosecond Ablation Tech

Bio-Thera Solutions Licenses BAT2506 to Intas Pharmaceuticals for US Market
CompanyDeals

Bio-Thera Solutions Licenses BAT2506 to Intas Pharmaceuticals for US Market

Changchun GeneScience's GenSci120 Receives NMPA Approval for Rheumatoid Arthritis Trials
CompanyDrug

Changchun GeneScience’s GenSci120 Receives NMPA Approval for Rheumatoid Arthritis Trials

CARsgen's Allogeneic BCMA CAR-T Therapy Achieves sCR in First Patient
CompanyDrug

CARsgen’s Allogeneic BCMA CAR-T Therapy Achieves sCR in First Patient

Haisco Pharmaceutical Group Registers Delaware Subsidiary to Expand Global Operations
Company

Haisco Pharmaceutical Group Registers Delaware Subsidiary to Expand Global Operations